Clinical Trials Directory

Trials / Unknown

UnknownNCT03316612

The Effect of Vaccinium Myrtillus L. Extract Intake on Human Metabolism

The Effect of Vaccinium Myrtillus L. Extract Intake on Human Metabolism: A Randomized Double-Blind Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Advanced glycation end-products (AGEs) has been linked to ageing, and many metabolic diseases. The findings of previous experiments suggested that the extracts from polyphenol-rich bilberry might inhibit the formation of AGEs. This is a randomized double-blind trial, aims to study the effect of Vaccinium Myrtillus L. natural extracts on AGEs and human metabolism. Firstly, we will investigate the efficacy of Bilberry extracts on lowering the levels of advanced glycation end-products (AGEs). Secondly, we will conduct 16S rRNA sequencing and ultra-high performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) detection to explore the role of bilberry extracts on gut microbiota as well as metabolites.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVaccinium Myrtillus L. extractTwice a day, 2 tablets each time. Do not take any other medicine, traditional Chinese medicine, or dietary supplements.
DIETARY_SUPPLEMENTPlaceboTwice a day, 2 tablets each time. Do not take any other medicine, traditional Chinese medicine, or dietary supplements.

Timeline

Start date
2017-11-10
Primary completion
2018-06-30
Completion
2018-10-30
First posted
2017-10-20
Last updated
2018-04-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03316612. Inclusion in this directory is not an endorsement.